Metabolite Identification

Accurate and confident metabolite identification (MetID) is essential for understanding drug metabolism, characterizing biotransformation pathways, and supporting regulatory submissions. Thermo Fisher Scientific delivers a comprehensive portfolio of solutions that support both small molecule and biologic drug development, from early discovery to late-stage studies.​

Whether you are analyzing synthetic compounds or complex biotherapeutics, our technologies help streamline both targeted and untargeted workflows. Achieve greater confidence in metabolite structure elucidation, reduce ambiguity in metabolic pathways, and accelerate development timelines.​

With Thermo Fisher Scientific, you can confidently identify and characterize metabolites across diverse therapeutic modalities—helping to ensure data quality, regulatory readiness, and scientific insight.​